Federal authorities have concluded their regulatory pursuit of executive-level opportunism at medical network provider Doximity Inc. The U.S. District Court for the Southern District of New York (SDNY) has entered a final consent judgment against Paul Jorgensen, the former Chief Revenue Officer of Doximity, resolving civil charges brought by the Securities and Exchange Commission surrounding illegal front-running of negative corporate announcements.
The regulatory judgment permanently bars Jorgensen from serving as an officer or director of a public issuer and orders more than $3 million in civil disgorgement. Under the terms of the settlement, the civil monetary sanction was largely offset by forfeiture orders established in his companion criminal prosecution, leaving a net cash balance of $490,077 payable directly to the Commission.
Trading Ahead of Downside Forecasts and Internal Layoffs
Jorgensen's prosecution stemmed from trading conduct in 2022 and 2023 that targeted weaknesses in his own firm's top-line revenue performance. According to the SEC's complaint and parallel criminal filings, Jorgensen liquidated 61,162 shares of Doximity equity immediately ahead of a quarterly earnings release, armed with non-public internal bookings data indicating that the platform would substantially miss its published revenue estimates.
Even more egregious from an internal governance perspective was Jorgensen’s subsequent use of derivative instruments. In 2023, possessing non-public operational briefings outlining planned corporate cost reductions—specifically including impending companywide layoffs and his own planned termination—Jorgensen acquired short-dated put options on Doximity equity. When the layoffs and downward revenue revisions were publicly disseminated, the resulting share price collapse yielded significant illicit derivative returns.
The Criminal-Regulatory Convergence
The civil resolution follows Jorgensen's sentencing in May to 26 months in federal prison and 24 months of supervised release, accompanied by a $2.5 million criminal forfeiture order. For forensic analysts, the case serves as a masterclass in the digital paper trail left behind by modern executive trading.
Executive front-running through derivative put positions represents one of the most visible forms of asymmetric insider exploitation. Historically, corporate insiders attempted to disguise exits through discretionary 10b5-1 plans or third-party entities. Jorgensen’s direct accumulation of put options right before negative internal corporate announcements provided regulators with clear statistical evidence of scienter. The lifetime officer-and-director bar ensures that corporate boards and audit committees will permanently exclude the former executive from public company leadership roles.
Key Takeaways
- SDNY entered a final consent judgment against former Doximity CRO Paul Jorgensen, settling civil SEC insider trading claims.
- Jorgensen was ordered to pay over $3 million in total disgorgement (offset by prior criminal forfeiture to $490,077) and received a permanent public company officer-and-director ban.
- The charges stemmed from dumping 61,162 shares ahead of weak earnings in 2022 and buying put options ahead of company layoffs in 2023.
- In parallel criminal proceedings, Jorgensen had previously pleaded guilty and was sentenced to 26 months in federal prison.
Sources
- Investment Executive — Court report on SDNY consent judgment and permanent ban against Paul Jorgensen, September 11–14, 2026.
- U.S. District Court for the Southern District of New York / SEC — Litigation records regarding SEC v. Paul Jorgensen (insider trading and put option manipulation), 2026.
Original reporting by Investment Executive. This article is desk analysis prepared by The Forensic Ledger from publicly available sources, summarized with citation to the original.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.
